Tool
Stock screener
Filter the 3753 large-cap US stocks StockVane tracks, then sort by any column. Results carry the same Quant Rating shown on each stock’s page.
Top Quant-ratedLarge-cap dividend payersCheap & top-ratedBeaten-down (down 20%+ 1yr)High yield (4%+)Mega-cap winners
25 matches
| Company | 60d | Last | Chg% | Mkt cap | P/E | Yield | 1-yr | Quant ↑ |
|---|---|---|---|---|---|---|---|---|
| AlvotechALVO | 5.85 | -4.72% | $2.09B | -- | -- | -32.6% | D 10 | |
| PerrigoPRGO | 14.55 | +3.93% | $2.02B | -- | 7.97% | -28.0% | D 11 | |
| Prestige Consumer HealthcarePBH | 47.57 | +2.43% | $2.25B | 13.32 | -- | -24.8% | E 14 | |
| ANI PharmaceuticalsANIP | 71.93 | +0.57% | $1.65B | 15.67 | -- | -21.5% | D 17 | |
| Hutchmed (China)HCM | 14.28 | -2.19% | $2.49B | 178.50 | -- | -12.9% | D 26 | |
| Supernus PharmaceuticalsSUPN | 43.05 | +0.51% | $2.51B | -- | -- | -10.3% | D 27 | |
| EvotecEVO | 1.61 | -1.23% | $572.18M | -- | -- | -59.5% | F 33 | |
| Phibro Animal HealthPAHC | 37.72 | +3.03% | $1.53B | 15.52 | 1.27% | +2.9% | D 40 | |
| HarrowHROW | 30.62 | +0.89% | $1.15B | -- | -- | -22.9% | D 42 | |
| Neurocrine BiosciencesNBIX | 143.47 | -1.40% | $14.58B | 20.98 | -- | +3.2% | D 43 | |
| HaleonHLN | 9.02 | +1.69% | $39.67B | 18.87 | 2.11% | +1.8% | D 45 | |
| Elanco Animal HealthELAN | 22.36 | -0.53% | $11.17B | -- | -- | +9.9% | D 49 | |
| BioCryst PharmaceuticalsBCRX | 8.40 | +5.66% | $2.15B | -- | -- | +15.4% | D 61 | |
| Pacira BioSciencesPCRX | 25.20 | +1.78% | $1.00B | 72.00 | -- | +7.6% | C 62 | |
| Amphastar PharmaceuticalsAMPH | 25.54 | -1.43% | $1.09B | 15.11 | -- | -1.7% | C 66 | |
| Xeris PharmaceuticalsXERS | 10.11 | +0.40% | $1.84B | -- | -- | +23.3% | C 66 | |
| Cronos GroupCRON | 3.24 | -1.37% | $1.19B | 17.05 | -- | +20.9% | C 68 | |
| EvolusEOLS | 7.74 | +4.88% | $511.23M | -- | -- | +24.6% | B 75 | |
| Ironwood PharmaceuticalsIRWD | 3.75 | +3.31% | $619.65M | 4.75 | -- | +137.3% | B 83 | |
| IndiviorINDV | 36.13 | +0.64% | $4.26B | 12.95 | -- | +50.1% | B 86 | |
| Amneal PharmaceuticalsAMRX | 19.65 | -3.18% | $6.28B | 40.94 | -- | +87.5% | B 92 | |
| Teva Pharmaceutical IndustriesTEVA | 39.18 | +0.13% | $45.70B | 65.30 | -- | +93.9% | B 93 | |
| Kiniksa Pharmaceuticals InternationalKNSA | 77.96 | +1.13% | $6.08B | 78.75 | -- | +103.5% | B 94 | |
| Amylyx PharmaceuticalsAMLX | 27.43 | -2.18% | $3.44B | -- | -- | +103.5% | B 95 | |
| Eton PharmaceuticalETON | 54.88 | +0.20% | $1.57B | 140.72 | -- | +162.2% | B 97 |
Reference only, not investment advice. A screen is a starting point, not a buy list. Quant Rating method: Data & Methodology.